亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。

Treatment of Pulmonary Disorders with Retinoic Acid or Other Retinoids by Inducing Formation of Gas-Exchange Units (Alveoli)

詳細技術說明
The present invention relates to the treatment of Emphysema by usingRetinoic acid, its esters and the analogues. These compounds, whenadministered, either bucally, sublingually or by nebulizer, result inenhancing alveolar function or development; and thus offer greattherapeutic and commercial potential in treating pulmonary diseasesinvolving alveolar dysfunction, such as emphysema.
*Abstract

*Publications
"Retinoic acid treatment abrogates elastase-induced pulmonary emphysema in rats," Massaro et al, Nature Medicine, vol. 3, No. 6,675-677 (1997). "Postnatal treatment with retinoic acid increases the number of pulmonary alveoli in rats," Massaro et al, Am. J. Physiol., 270, L305-L310 (1996).
*Stage of Development
Proof-of-concept demonstrated in mice.
國家/地區
美國

欲了解更多信息,請點擊 這裡
移動設備